Search Results for: SMAD3

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
TGIF1 TGFB induced factor homeobox 1
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Holoprosencephaly (HPE)
TGIF2 TGFB induced factor homeobox 2
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Negative Regulation of CDH1 Gene Transcription
TGM2 transglutaminase 2
  • Guanosine-5'-Diphosphate
  • Hexylresorcinol
TLE5 TLE family member 5, transcriptional modulator
  • Repression of WNT target genes
TLR4 toll like receptor 4
  • ER-Phagosome pathway
  • Caspase activation via Death Receptors in the presence of ligand
  • Toll Like Receptor 4 (TLR4) Cascade
  • MyD88:MAL(TIRAP) cascade initiated on plasma membrane
  • MyD88-independent TLR4 cascade
  • TRIF-mediated programmed cell death
  • MyD88 deficiency (TLR2/4)
  • IRAK4 deficiency (TLR2/4)
  • Regulation of TLR by endogenous ligand
  • Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE)
  • IKK complex recruitment mediated by RIP1
  • TRAF6-mediated induction of TAK1 complex within TLR4 complex
  • Heme signaling
  • IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
  • Respiratory syncytial virus (RSV) attachment and entry
  • Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7
  • RSV-host interactions
  • Cyclobenzaprine
  • Naloxone
  • (R)-3-hydroxytetradecanoic acid
  • Lauric acid
  • Eritoran
  • Golotimod
  • E5531
  • Myristic acid
  • Papain
  • Mifamurtide
  • Macular degeneration, including: Age-related macular degeneration (ARMD); Patterned dystrophy of retinal pigment epithelium (PDREP); Retinal macular dystrophy 2 (MCDR2); X-linked atrophic macular degeneration (MDXLA)
TMED1 transmembrane p24 trafficking protein 1
TOB1 transducer of ERBB2, 1
TP53 tumor protein p53
  • Activation of NOXA and translocation to mitochondria
  • Activation of PUMA and translocation to mitochondria
  • Pre-NOTCH Transcription and Translation
  • Oxidative Stress Induced Senescence
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
  • Oncogene Induced Senescence
  • DNA Damage/Telomere Stress Induced Senescence
  • SUMOylation of transcription factors
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Association of TriC/CCT with target proteins during biosynthesis
  • Pyroptosis
  • TP53 Regulates Metabolic Genes
  • Ub-specific processing proteases
  • Ovarian tumor domain proteases
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Interleukin-4 and Interleukin-13 signaling
  • TP53 Regulates Transcription of DNA Repair Genes
  • TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
  • TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
  • TP53 Regulates Transcription of Caspase Activators and Caspases
  • TP53 Regulates Transcription of Death Receptors and Ligands
  • TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
  • TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
  • TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
  • Regulation of TP53 Expression
  • Regulation of TP53 Activity through Phosphorylation
  • Regulation of TP53 Degradation
  • Regulation of TP53 Activity through Acetylation
  • Regulation of TP53 Activity through Association with Co-factors
  • Regulation of TP53 Activity through Methylation
  • PI5P Regulates TP53 Acetylation
  • G2/M DNA damage checkpoint
  • G2/M Checkpoints
  • Stabilization of p53
  • Transcriptional activation of cell cycle inhibitor p21
  • The role of GTSE1 in G2/M progression after G2 checkpoint
  • Transcriptional Regulation by VENTX
  • RUNX3 regulates CDKN1A transcription
  • Regulation of PTEN gene transcription
  • Regulation of PTEN gene transcription
  • Loss of function of TP53 in cancer due to loss of tetramerization ability
  • Signaling by ALK fusions and activated point mutants
  • Regulation of NF-kappa B signaling
  • Zygotic genome activation (ZGA)
  • Factors involved in megakaryocyte development and platelet production
  • PKR-mediated signaling
  • Acetylsalicylic acid
  • Zinc
  • Triethyl phosphate
  • AZD 3355
  • 1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Chronic myeloid leukemia (CML)
  • Breast cancer
  • Non-small cell lung cancer
  • Gastric cancer
  • Adult T-cell leukemia
  • Choriocarcinoma
  • Esophageal cancer
  • Glioma
  • Pancreatic cancer
  • Vulvar cancer
  • Multiple myeloma
  • Choroid plexus papilloma
  • Ovarian cancer
  • Hepatocellular carcinoma
  • Squamous cell carcinoma
  • Endometrial Cancer
  • Penile cancer
  • Cancer of the anal canal
  • Hairy-cell leukemia
  • Oral cancer
  • Adrenal carcinoma
  • Malignant melanoma
  • Burkitt lymphoma
  • Thyroid cancer
  • Basal cell carcinoma
  • Small cell lung cancer
  • Gallbladder cancer
  • Bladder cancer
  • Laryngeal cancer
  • Kaposi's sarcoma
  • Cholangiocarcinoma
  • Chronic lymphocytic leukemia (CLL)
  • Li-Fraumeni syndrome, including: Classic Li-Fraumeni syndrome (LFS); LFS-like syndrome (LFSL)
  • Malignant pleural mesothelioma
  • Osteosarcoma
  • Colorectal cancer
TP73 tumor protein p73
  • Activation of PUMA and translocation to mitochondria
  • TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
  • TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
  • TP53 Regulates Transcription of Caspase Activators and Caspases
  • TP53 Regulates Transcription of Death Receptors and Ligands
  • Regulation of TP53 Activity through Association with Co-factors
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • Zinc
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Hepatocellular carcinoma
TPM3 tropomyosin 3
  • Striated Muscle Contraction
  • Smooth Muscle Contraction
  • RHOV GTPase cycle
  • Signaling by ALK fusions and activated point mutants
  • Phenethyl Isothiocyanate
  • Congenital fiber type disproportion (CFTD)
  • Cap myopathy
  • Thyroid cancer
  • Nemaline myopathy
TRIM33 tripartite motif containing 33
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • Germ layer formation at gastrulation
TSC2 TSC complex subunit 2
  • Macroautophagy
  • Inhibition of TSC complex formation by PKB
  • AKT phosphorylates targets in the cytosol
  • Energy dependent regulation of mTOR by LKB1-AMPK
  • TP53 Regulates Metabolic Genes
  • Constitutive Signaling by AKT1 E17K in Cancer
  • TBC/RABGAPs
  • Lymphangioleiomyomatosis (LAM)
  • Tuberous sclerosis complex (TSC); Bourneville-Pringle disease
TSC22D4 TSC22 domain family member 4
UBQLN4 ubiquilin 4
UCHL5 ubiquitin C-terminal hydrolase L5
  • Downregulation of TGF-beta receptor signaling
  • UCH proteinases
  • UCH proteinases
USP7 ubiquitin specific peptidase 7
  • Ub-specific processing proteases
  • Formation of TC-NER Pre-Incision Complex
  • Transcription-Coupled Nucleotide Excision Repair (TC-NER)
  • Dual incision in TC-NER
  • Gap-filling DNA repair synthesis and ligation in TC-NER
  • Regulation of TP53 Degradation
  • Synthesis of active ubiquitin: roles of E1 and E2 enzymes
  • Regulation of PTEN localization
VDR vitamin D receptor
  • Vitamin D (calciferol) metabolism
  • Nuclear Receptor transcription pathway
  • SUMOylation of intracellular receptors
  • Calcitriol
  • Calcifediol
  • Ergocalciferol
  • Cholecalciferol
  • Paricalcitol
  • Dihydrotachysterol
  • Alfacalcidol
  • Calcipotriol
  • Lexacalcitol
  • Seocalcitol
  • Cholesterol
  • Inecalcitol
  • Becocalcidiol
  • CTA018
  • Eldecalcitol
  • Elocalcitol
  • Doxercalciferol
  • (1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol
  • 1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)
  • Vitamin D
  • Curcumin
  • Curcumin sulfate
  • Tuberculosis
  • Localized autosomal recessive hypotrichosis
VIM vimentin
  • Caspase-mediated cleavage of cytoskeletal proteins
  • Striated Muscle Contraction
  • Interleukin-4 and Interleukin-13 signaling
  • RHOBTB1 GTPase cycle
  • Chaperone Mediated Autophagy
  • Late endosomal microautophagy
  • Aggrephagy
  • Developmental Lineage of Mammary Gland Myoepithelial Cells
  • Artenimol
  • Phenethyl Isothiocyanate
VSIR V-set immunoregulatory receptor
WEE1 WEE1 G2 checkpoint kinase
  • Polo-like kinase mediated events
  • Cyclin E associated events during G1/S transition
  • Cyclin A/B1/B2 associated events during G2/M transition
  • G2/M DNA replication checkpoint
  • Cyclin A:Cdk2-associated events at S phase entry
  • Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
  • Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
  • Factors involved in megakaryocyte development and platelet production
  • 9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE
  • 9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE
  • N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE
  • 4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione
  • 3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID
  • 8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide
  • MK-1775
  • Fostamatinib

Page 13 out of 14 pages